Literature DB >> 28752798

Primary headaches in patients with temporomandibular disorders: Diagnosis and treatment of central sensitization pain.

Marco Sagripanti1, Carlotta Viti2.   

Abstract

OBJECTIVES: Central sensitization (CS) has been found in patients with temporomandibular disorders (TMD), craniofacial pain (CP) and primary headaches, but its clinical implications remain uncertain. The first aim was to provide a synthesis of the current state of knowledge about the link between CS and TMD associated with primary headaches; the second goal was to find methodologies to assess and treat CS in this subgroup of patients.
METHODS: A narrative review of the literature was conducted.
RESULTS: CS is described in literature as an aggravating factor in patients with TMD-related primary headaches. Further studies are required to support this assertion.
CONCLUSIONS: The importance of excluding chronic neuropathic pain and recognizing CS as the main component using a top-down approach to target the best pharmacological and non-pharmacological treatments is evident. Some useful tools to discriminate patients with CS from others have become available, but more research is required to enable an appropriate diagnosis.

Entities:  

Keywords:  Central nervous system sensitization; clinical reasoning; cranio-facial pain; decisional making; headache; pain management; temporo-mandibular disorders

Mesh:

Year:  2017        PMID: 28752798     DOI: 10.1080/08869634.2017.1359353

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  2 in total

1.  Physical therapist clinical reasoning and classification inconsistencies in headache disorders: a United States survey.

Authors:  Philip C Dale; Jacob C Thomas; Charles R Hazle
Journal:  J Man Manip Ther       Date:  2019-08-02

Review 2.  Juvenile Fibromyalgia and Headache Comorbidity in Children and Adolescents: A Literature Review.

Authors:  Emilia Matera; Roberto Palumbi; Antonia Peschechera; Maria Giuseppina Petruzzelli; Vittorio Sciruicchio; Marina de Tommaso; Lucia Margari
Journal:  Pain Res Manag       Date:  2019-06-03       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.